Adobe Reader is required to view the PDFs listed on this site. Click here to download the reader from Adobe's site.

November/December 2003 • Volume 12 • Number 6 Estrogen and Progestogen Use in Peri- and Postmenopausal Women: September 2003 Position Statement of The North American Menopause Society NAMS released a report on hormone therapy in 2002. In subsequent months, however, an influx of new clinical trial data led the organization to convene a second HT Advisory Panel to develop another report. After approval from the 2002-2003 NAMS Board of Trustees, this position statement was released on September 17, 2003, and is reprinted here. NAMS • p. 20 view PDF (256K) Does “Statistically Significant” Always Equate to “Clinically Relevant?” Utian WH • p. 9 view PDF (68K) What Your Patients Are Reading Earlier this year, NAMS launched Menopause Flashes, a unique consumer education newsletter that is e-mailed free to subscribers on a monthly basis. The publication contains the latest information and news about menopause in a fun, easy-to-read style and format. This article presents excerpts from Menopause Flashes to make readers aware of this important program. Boggs P • p. 11 view PDF (64K) News and Commentary • p. 19 NAMS News • p. 32 2003 Subject and Author Index • p. 30   Reprints and permissions Requests for reprints of Menopause Management articles or permissions to use article content may be sent to Jennifer Kenny at jkenny@menopausemgmt.com.

©2006 by HealthCom Media. All rights reserved. No part of this publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.